Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.

With regard to days to blast clearance, there was a small difference between the groups, but this did not reach statistical significance ( supplemental Figure 4 ).

also in 111,027 other papers